Position in TRDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,281,172
-$684,425 QoQ
Shares Held
309,942
+31.9% QoQ
Ownership
0.796%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. TRDA ranks #222 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in TRDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,281,172 | 309,942 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $2,965,597 | 234,992 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,326,372 | 226,301 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,470,920 | 253,607 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,018,157 | 300,321 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,804,089 | 310,187 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,501,278 | 318,177 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,957,925 | 247,680 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,711,902 | 190,309 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,824,675 | 199,342 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,028,381 | 200,688 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,239,962 | 205,061 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,938,582 | 194,094 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $484,198 | 33,393 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $464,547 | 34,360 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $472,752 | 29,997 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $198,875 | 16,328 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $847,522 | 90,258 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,360,748 | 79,483 | Shares | Defined | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||